Who owns Caris Life Sciences, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CAI from SEC Form 13F filings across 329 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 329 institutions disclosed 155.1M shares of Caris Life Sciences, Inc. worth $4.75B — about 54.6% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
329
13F holders
$4.75B
value, 2026 filers
54.6%
of shares outstanding (155.1M sh)
124
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of CAI's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 38.3M | $1.17B | 0.1% | 13.5% | +24.0% |
| 2 | AQR CAPITAL MANAGEMENT LLC | 8.2M | $251.5M | 0.1% | 2.9% | +13791.8% |
| 3 | BlackRock, Inc. | 7.9M | $240.9M | 0.0% | 2.8% | +42.0% |
| 4 | D. E. Shaw & Co., Inc. | 7.2M | $221.1M | 0.1% | 2.5% | +3424.2% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 5.7M | $175.6M | 0.0% | 2% | +34.0% |
| 6 | PRICE T ROWE ASSOCIATES INC /MD/ | 4.8M | $147.5M | 0.0% | 1.7% | +299.4% |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.7M | $144.9M | 0.0% | 1.7% | -2.4% |
| 8 | Capital World Investors | 4.4M | $134.4M | 0.0% | 1.5% | +261.8% |
| 9 | BNP PARIBAS FINANCIAL MARKETS | 3.5M | $107.6M | 0.0% | 1.2% | +48.2% |
| 10 | JPMORGAN CHASE & CO | 3.4M | $108.7M | 0.0% | 1.2% | -47.6% |
| 11 | Sixth Street Partners Management Company, L.P. | 3.0M | $92.9M | 19.2% | 1.1% | -58.6% |
| 12 | LOS ANGELES CAPITAL MANAGEMENT LLC | 3.0M | $90.8M | 0.3% | 1% | -25.1% |
| 13 | BRAIDWELL LP | 2.7M | $84.1M | 3.5% | 1% | -66.7% |
| 14 | UBS Group AG | 2.5M | $75.7M | 0.0% | 0.9% | +73.5% |
| 15 | MORGAN STANLEY | 2.4M | $73.9M | 0.0% | 0.8% | +24.6% |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | 2.4M | $73.3M | 0.0% | 0.8% | +128.9% |
| 17 | Amundi | 2.3M | $71.8M | 0.0% | 0.8% | +92.4% |
| 18 | ORBIMED ADVISORS LLC | 2.2M | $67.2M | 1.2% | 0.8% | -21.9% |
| 19 | MAK CAPITAL ONE LLC | 2.2M | $65.9M | 10.5% | 0.8% | +11.1% |
| 20 | STATE STREET CORP | 2.1M | $65.5M | 0.0% | 0.8% | +75.7% |
| 21 | J. H. Whitney Equity Partners VI, LLC | 1.8M | $53.6M | 100.0% | 0.6% | -84.4% |
| 22 | FIL Ltd | 1.6M | $48.5M | 0.0% | 0.6% | +2.2% |
| 23 | Clearbridge Investments, LLC | 1.6M | $48.0M | 0.0% | 0.6% | -1.8% |
| 24 | MILLENNIUM MANAGEMENT LLC | 1.6M | $47.9M | 0.0% | 0.6% | -28.9% |
| 25 | Walleye Capital LLC | 1.5M | $44.5M | 0.0% | 0.5% | +242.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.